Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5615135 | Journal of Clinical Lipidology | 2017 | 36 Pages |
Abstract
HDL isolated from individuals with type II diabetes showed a decreased ability to suppress inflammation. However, the direction of causality and the underlying mechanisms are unknown and should be investigated. For development of treatments directed at restoring HDL anti-inflammatory function in diabetes, a standardized method for assessing HDL anti-inflammatory function needs to be developed and in vivo biomarkers must be identified.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Roosmarijn F.H. MD, Mandy MD, PhD, Aloysius G. MD, PhD, Adrie J.M. PhD, Eric J.G. MD, PhD, Monique T. PhD,